Earnings · China A-shares
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A (603707) earnings
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -36.40% year on year, -41.42% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved +0.25% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -36.40%
- Excl. one-offs YoY
- -41.42%
- Net profit QoQ
- -13.13%
- Result
- Bad / loss
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.11% | — |
| 3 days | +0.25% | — |
| 7 days | +6.31% | — |
| 14 days | +0.99% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 4 of 6 reports (average -1.21%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥273.15M | -36.40% | -41.42% | +2.74% | 0.17 | 3.92% | +0.25% | — | — |
| 2026 interim report | 2026-08-28 | ¥187.55M | -34.48% | -43.75% | -2.71% | 0.12 | 2.69% | +1.58% | -1.09% | +8.60% |
| 2026 Q1 report | 2026-04-30 | ¥89.01M | +5.07% | -24.89% | +4.91% | 0.06 | 1.28% | -3.60% | -20.87% | -22.92% |
| 2025 annual report | 2026-04-30 | ¥581.54M | -29.61% | -35.73% | +1.71% | 0.36 | 8.68% | -3.60% | -20.87% | -22.92% |
| 2025 Q3 report | 2025-10-25 | ¥429.47M | -29.11% | -29.95% | -5.25% | 0.27 | 6.47% | +1.45% | -0.41% | -0.19% |
| 2025 interim report | 2025-08-29 | ¥286.27M | -29.32% | -29.46% | -7.60% | 0.18 | 4.34% | +1.66% | -10.54% | -11.81% |
| 2025 Q1 report | 2025-04-29 | ¥84.71M | -52.19% | -56.05% | -11.85% | 0.05 | 1.30% | -8.59% | +0.18% | -2.40% |
| 2024 annual report | 2025-04-29 | ¥826.14M | +536.09% | +566.00% | -0.20% | 0.51 | 13.47% | -8.59% | +0.18% | -2.40% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.